Ranok Therapeutics
Hangzhou
About Ranok Therapeutics
Ranok Therapeutics is a biotechnology company that is developing a novel targeted protein degradation technology to aid in the discovery and development of novel therapeutics. Ranok's TPD technology engages various underlying biological processes and outperforms competing TPD approaches. Ranok's pipeline contains both well-validated and novel drug targets involved in cancer and other diseases with significant unmet medical needs. Ranok is dedicated to developing the next generation of cancer therapies that are both safer and more effective.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2021)
- Website: ranoktherapeutics.com
- Phone: 0571-86630936
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/ranok-therapeutics-120124 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.